The Role of Olive Oil in the Treatment of Covid-19 Pneumonia

NCT ID: NCT06677658

Last Updated: 2024-11-07

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 130 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2022-01-01
• Study Completion Date: 2022-09-07

Brief Summary

Objective: Consuming natural olive oil in patients diagnosed with COVID-19 Pneumonia may strengthen immunity, slow down disease progression, and lower mortality. Within the scope of this research, the investigators aimed to elucidate the effect of using natural olive oil on clinical, laboratory, and radiological findings and survival in patients diagnosed with COVID-19 pneumonia and given pulse steroid treatment.

Method: This retrospective observational research enrolled 130 patients diagnosed with COVID-19 pneumonia. Participants were examined in two groups according to their olive oil consumption status. Patients diagnosed with COVID-19 pneumonia treated with pulse steroids for three days who routinely consumed oral olive oil in their daily diets were defined as Group 1, and those who did not consume olive oil were defined as Group 2.

Detailed Description

Introduction: In the COVID-19 pandemic, many patients with lung involvement who received pulse steroid treatment showed improvement in clinical, laboratory, radiological, and survival parameters. It was observed that a significant number of patients who showed improvement consumed natural olive oil, and while the follow-up and treatment of these patients continued, the effect of oral consumption of natural olive oil on clinical, laboratory parameters, and survival of the patients was the subject of research [1]. The benefits of olive oil consumption can be increased through physical activity, especially strength and resistance exercise. Such an approach is likely to prevent viral infections effectively. In terms of the recommended dose of olive oil, a moderate dose of 20-30 grams/day (especially extra virgin olive oil rich in polyphenols) can be recommended in combination with other dietary functional foods to strengthen the immune system, which is in line with the latest non-communicable disease prevention recommendations [1, 2]. The Mediterranean diet, which includes extra virgin olive oil and a correct lifestyle, can prevent low-grade inflammation and other chronic pathologies by directly affecting the intestinal microbiota and the immune system. A study has stated that olive oil can be used pharmacotherapeutically against SARS-CoV 2 [3]. In this context, it has been predicted that the consumption of natural olive oil in patients diagnosed with COVID-19 Pneumonia may strengthen immunity, slow down disease progression, and lower mortality. Within the scope of this research, we aimed to elucidate the effect of using natural olive oil on clinical, laboratory, and radiological findings and survival in patients diagnosed with COVID-19 pneumonia and given pulse steroid treatment.

Method: This retrospective observational research enrolled 130 patients diagnosed with COVID-19 pneumonia, confirmed with real-time polymerase chain reaction (RT-PCR). The patients were segmented into two groups (n=65 in each) according to their olive oil consumption. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Ethics committee approval has been granted from our institution with protocol number 22.05.2024/03, and informed consent has been obtained from all participants.

Participants were examined in two groups according to their olive oil consumption status. Patients diagnosed with COVID-19 pneumonia treated with pulse steroids ( methylprednisolone 250 mg/day) for three days and routinely consumed at least 20 ml olive oil in their daily diets were defined as Group 1. Patients of similar age and gender with COVID-19 pneumonia who received the same treatment but did not consume olive oil were defined as Group 2.

References:

1. Soo CI, Poon KV, Ayub A, You HW, Tan CX, Loh KJJ, et al. High-dose pulse methylprednisolone vs. dexamethasone standard therapy for severe and critical COVID-19 pneumonia: Efficacy assessment in a retrospective single-centre experience from Malaysia. Medical Journal of Malaysia. 2024;79(1):15-20.

2. Alkhatib A. Antiviral functional foods and exercise lifestyle prevention of coronavirus. Nutrients. 2020;12(9):2633. doi: 10.3390/nu12092633.

3. Hendi AA, Virk P, Awad MA, Elobeid M, Ortashi KM, Alanazi MM, et al. In silico studies on zinc oxide based nanostructured oil carriers with seed extracts of Nigella sativa and Pimpinella anisum as potential inhibitors of 3CL protease of SARS-CoV-2. Molecules. 2022;27(13):4301. doi: 10.3390/molecules27134301.

Conditions

COVID-19 Pneumonia; Nutrition, Healthy

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: RETROSPECTIVE

Study Groups

Group 1

Patients diagnosed with COVID-19 pneumonia treated with pulse steroids (250 mg/day) for three days and routinely consumed at least 20 ml/day olive oil in their diets were defined as Group 1.

Olive Oil

Intervention Type: DIETARY_SUPPLEMENT

Group 1 included patients who consumed at least 20 ml of oral olive oil daily. Group 2 included patients who did not consume olive oil.

Methylprednisolone

Intervention Type: DRUG

Both groups were diagnosed with Covid-19 pneumonia and were given pulse steroid ( methylprednisolone ) treatment at 250 mg/day for 3 days.

Group 2

Patients of similar age and gender with COVID-19 pneumonia who received the same treatment but did not consume olive oil were defined as Group 2.

Methylprednisolone

Intervention Type: DRUG

Both groups were diagnosed with Covid-19 pneumonia and were given pulse steroid ( methylprednisolone ) treatment at 250 mg/day for 3 days.

Interventions

Olive Oil

Group 1 included patients who consumed at least 20 ml of oral olive oil daily. Group 2 included patients who did not consume olive oil.

Intervention Type: DIETARY_SUPPLEMENT

Methylprednisolone

Both groups were diagnosed with Covid-19 pneumonia and were given pulse steroid ( methylprednisolone ) treatment at 250 mg/day for 3 days.

Intervention Type: DRUG

Other Intervention Names

Pulse steroid

Eligibility Criteria

Inclusion Criteria

• The study included patients aged ≥18 who were diagnosed with COVID-19 and had lung involvement (COVID-19 pneumonia).

Exclusion Criteria

• Patients under the age of 18, pregnant women, individuals intubated due to severe respiratory failure in COVID-19 pneumonia, and those who received alternative treatments other than pulse steroid treatment (Immunoplasma, Tocilizumab, Anakinra, Plasmapheresis, Stem Cell Therapy, etc.) were excluded

• Minimum Eligible Age: 27 Years
• Maximum Eligible Age: 95 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Giresun University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Selda Günaydın, MD

Role: STUDY_CHAIR

Assistant researcher

Ersin Kuloğlu, MD

Role: STUDY_CHAIR

Assistant researcher

Gökhan Aydın, MD

Role: STUDY_CHAIR

Assistant researcher

Locations

Giresun Training and Research Hospital

Giresun, Giresun, Turkey (Türkiye)

Countries

Turkey (Türkiye)

References

Soo CI, Poon KV, Ayub A, You HW, Tan CX, Loh KJJ, Eng CCH, Sia LC, Wong CK. High-dose pulse methylprednisolone vs. dexamethasone standard therapy for severe and critical COVID-19 pneumonia: Efficacy assessment in a retrospective single-centre experience from Malaysia. Med J Malaysia. 2024 Jan;79(1):15-20.

Reference Type: BACKGROUND

PMID: 38287752 (View on PubMed)

Alkhatib A. Antiviral Functional Foods and Exercise Lifestyle Prevention of Coronavirus. Nutrients. 2020 Aug 28;12(9):2633. doi: 10.3390/nu12092633.

Reference Type: BACKGROUND

PMID: 32872374 (View on PubMed)

Hendi AA, Virk P, Awad MA, Elobeid M, Ortashi KMO, Alanazi MM, Alkallas FH, Almoneef MM, Abdou MA. In Silico Studies on Zinc Oxide Based Nanostructured Oil Carriers with Seed Extracts of Nigella sativa and Pimpinella anisum as Potential Inhibitors of 3CL Protease of SARS-CoV-2. Molecules. 2022 Jul 4;27(13):4301. doi: 10.3390/molecules27134301.

Reference Type: BACKGROUND

PMID: 35807545 (View on PubMed)

Other Identifiers

22.05.2024-03

Identifier Type: -

Identifier Source: org_study_id